<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        4-828-16
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2016
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        FASIGYN 500MG TABLET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        TINIDAZOLE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        500
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        4
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        14.95
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Fareva Amboise" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Fareva Amboise
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 583]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ALNAGHI COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            PFIZER
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01XD02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Fasigyn 500mg film-coated tablets contain 500mg of the active substance tinidazole.&nbsp; This medicine is an anti-infective agent. It is used to treat a variety of bacterial infections including:</p><p>&bull; infections of the skin, blood, chest, lung, genitals or womb lining.</p><p>&bull; an infection associated with stomach ulcers in combination with other drugs.</p><p>&bull; infections caused by organisms called protozoa, such as amoebiasis and giardiasis (stomach infections) and trichomoniasis (a genital infection).</p><p>&bull; vaginal infections (vaginitis) and gum infections (gingivitis).</p><p>&nbsp;</p><p>It is also used before certain surgical operations to prevent bacterial infections developing.</p><p>You should ask your doctor if you are unsure why you have been given this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Fasigyn 500mg film-coated tablets if:</strong></p><p>&bull; you are allergic (hypersensitive) to tinidazole or any similar drugs or to any of the other ingredients listed in section 6. An allergic reaction could cause itching, a skin rash or wheezing.</p><p>&bull; you have a blood disorder or a history of blood disorders</p><p>&bull; you have central nervous system (CNS) disease, including epilepsy</p><p>&bull; you are in the first 13 weeks of pregnancy or trying to become pregnant or you are breast-feeding.</p><p>&nbsp;</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor, pharmacist or nurse, if during therapy with Fasigyn 500mg film-coated tablets abnormal neurological signs develop (such as, dizziness, vertigo, difficulty in controlling movements) as you may be told to stop your treatment.</p><p>&nbsp;</p><p><strong>Other medicines and Fasigyn 500mg film-coated tablets</strong></p><p>Tell your doctor if you are taking or have recently taken any other medicines including those obtained without a prescription.</p><p>You should tell your doctor if you are currently taking blood thinners such as warfarin to prevent blood clots as your doctor may wish to monitor you more closely.</p><p>&nbsp;</p><p><strong>Fasigyn 500mg film-coated tablets with food and drink</strong></p><p><strong>You should not drink wine, beer or spirits</strong> during treatment and for 3 days after stopping treatment with this medicine. The combination may cause flushing, stomach cramps, vomiting (being sick) and palpitations (pounding heart).</p><p><strong>&nbsp;</strong></p><p><strong>Pregnancy</strong></p><p><strong>&nbsp;</strong></p><p>You should not take this medicine if you are in the first 13 weeks of pregnancy or are trying to become pregnant. Ask your doctor or pharmacist for advice about taking this medicine in the second and third trimester of pregnancy.<em> </em>Always ask your doctor or pharmacist for advice before taking Fasigyn 500mg film-coated tablets or any other medicine.</p><p>&nbsp;</p><p><strong>Breast-feeding</strong></p><p>You should not take this medicine if you are breast-feeding as small amounts can pass into your milk. If you stop breast-feeding during treatment you should not start again until at least 3 days after stopping Fasigyn 500mg film-coated tablets.</p><p>&nbsp;</p><p><strong>Fertility</strong></p><p>Male and female fertility may be affected when taking Fasigyn 500mg film-coated tablets, therefore talk to your doctor if you are planning to have a baby.</p><p>&nbsp;</p><p><strong>Driving and using machines</strong></p><p>Do not drive or use machinery if this medicine makes you feel drowsy or gives you problems with co-ordination or sensation (e.g. numbness or weakness).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</p><p>Take Fasigyn 500mg film-coated tablets with a glass of water during or after a meal. Swallow the tablets whole. It is best to take the medicine at the same time each day.</p><p>&nbsp;</p><p><strong>Use in children under 12 years</strong></p><p>For bacterial infections, this medicine is not recommended for use in children less than 12 years as it has not been tested in this age group.</p><p>For protozoal infections, Fasigyn 500mg film-coated tablets can be used in children and has not been shown to cause any different side effects or more problems than it does in adults.</p><p>The dose and length of treatment depends upon the infection being treated. If you are on dialysis, your doctor may prescribe a different dose.</p><p>&nbsp;</p><p>The doses most commonly used for the different infections are shown in the table below:</p><p>&nbsp;</p><p><strong>For treating the infection associated with stomach ulcers</strong></p><p>The usual dose is 1 tablet (500mg) taken twice a day. Your doctor will probably prescribe two other medicines to be taken with Fasigyn 500mg film-coated tablets. Treatment with the three medicines together will usually be for 1 week.</p><p>&nbsp;</p><p><strong>For treating most bacterial infections</strong></p><p>The usual dose is 4 tablets (2g) on the first day then 2 tablets (1g) once a day or 1 tablet (500mg) twice a day.</p><p>The usual length of treatment is 5 to 6 days.</p><p>&nbsp;</p><p><strong>For treating bacterial vaginitis (a vaginal infection) and acute ulcerative gingivitis</strong></p><p><strong>(a gum infection)</strong></p><p>The usual dose is 4 tablets (2g) given as a single dose.</p><p>For vaginitis you may be given 4 tablets (2g) on two consecutive days.</p><p>&nbsp;</p><p><strong>For preventing bacterial infections after surgery</strong></p><p>Usually 4 tablets (2g) are given as a single dose about 12 hours before surgery.</p><p>&nbsp;</p><p><strong>For treating protozoal infections</strong></p><p>For treating intestinal amoebiasis (a stomach infection)</p><p><em><u>Adult</u></em> The usual dose is 4 tablets (2g) once a day for 2 to 3 days.</p><p><em><u>Child</u></em> The usual dose is 50 to 60mg/kg of body weight once a day for 3 days.</p><p>&nbsp;</p><p><strong>For treating amoebic involvement of the liver (a liver infection)</strong></p><p><em><u>Adult</u></em>&nbsp; The usual dose is 3 to 4 tablets (1.5 to 2g) once a day for 3 to 6 days.</p><p><em><u>Child</u> </em>The usual dose is 50 to 60mg/kg of body weight once a day for 5 days.</p><p>&nbsp;</p><p><strong>For treating giardiasis (an abdominal infection) and trichomoniasis (an infection of the sex organs in males and females)</strong></p><p><em><u>Adult </u></em>The usual dose is 4 tablets (2g) given as a single dose.</p><p><em><u>Child</u></em> The usual dose is 50 to 75mg/kg of body weight given as a single dose.</p><p>&nbsp;</p><p>Your doctor will calculate the dose required for a child and may repeat the dose once if the infection has not cleared up completely.</p><p>&nbsp;</p><p><strong>If you take more Fasigyn 500mg film-coated tablets than you should</strong></p><p>If you take too much of this medicine tell your doctor or contact your nearest hospital casualty department immediately. Take any remaining tablets with you.</p><p>&nbsp;</p><p><strong>If you forget to take Fasigyn 500mg film-coated tablets</strong></p><p>If you forget to take this medicine take it as soon as you can. Take your next dose at the right time. Do not take a double dose to make up for a forgotten dose.</p><p>&nbsp;</p><p><strong>If you stop taking Fasigyn 500mg film-coated tablets</strong></p><p>If you stop taking this medicine too soon, the infection may return. Take this medicine for the full time of treatment, even when you begin to feel better.</p><p>If you have any further questions about the use of this medicine, ask your doctor or pharmacist for advice.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine causes side effects, although not everybody gets them.</p><p>&nbsp;</p><p><strong>Tell your doctor immediately</strong> if you experience any of the following symptoms after taking this medicine.</p><p>Although they are very rare, the symptoms can be severe.</p><p>&bull; &nbsp;&nbsp;sudden wheeziness, difficulty in breathing, swelling of eyelids, face or lips or tongue</p><p>&bull;&nbsp; &nbsp;fits or seizures</p><p>&nbsp;</p><p>The common side effects (that may affect up to 1 in 10 people) are listed below. These may go away during treatment as your body adjusts to the medicine. Tell your doctor if any of these side effects continue to bother you.</p><p>&bull;&nbsp; &nbsp;nausea (feeling sick) or vomiting, loss of appetite, diarrhoea, stomach pain or cramps</p><p>&bull; &nbsp;&nbsp;headache</p><p>&bull;&nbsp;&nbsp; vertigo (See section 2 &lsquo;Warnings and precautions&rsquo;)</p><p>&bull;&nbsp;&nbsp; skin rash or itching (especially affecting the whole body).</p><p>&nbsp;</p><p>The frequency of the following side effects is not known (cannot be estimated from the available data). You should contact your doctor if you notice any of the following:</p><p>&bull;&nbsp;&nbsp; numbness, tingling, pain or weakness in hands or feet</p><p>&bull; &nbsp;&nbsp;clumsiness or unsteadiness</p><p>&bull; &nbsp;&nbsp;fever or chills and painful ulcers in the mouth</p><p>&bull;&nbsp; &nbsp;sore or swollen mouth/tongue</p><p>&bull;&nbsp;&nbsp; redness of the face or neck</p><p>&bull;&nbsp;&nbsp; dizziness</p><p>&bull;&nbsp;&nbsp; tiredness</p><p>&bull; &nbsp;&nbsp;dark urine</p><p>&bull;&nbsp; &nbsp;tongue discolouration or unpleasant metallic taste.</p><p>&nbsp;</p><p>Fasigyn 500mg film-coated tablets can sometimes cause a temporary reduction in white blood cells which does not usually give you any symptoms.</p><p>&nbsp;</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. By reporting side effects you can help provide more information on the safety of this medicine.</p><p><strong>&nbsp;</strong></p><p><strong>To Report side effects</strong></p><p>&nbsp;</p><ul><li>Saudi Arabia</li></ul><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>National Pharmacovigilance Centre ( NPC )</p><p>&middot;&nbsp;&nbsp; Call NPC at +966-11-2038222, Ext 2317-2356-2340</p><p>&middot;&nbsp;&nbsp; Call centre : 19999</p><p>&middot;&nbsp;&nbsp; Fax: +966 11 205 7662</p><p>&middot;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><ul><li>Website :https://ade.sfda.gov.sa/&nbsp;&nbsp;</li></ul><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other GCC States</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp; <em>Please contact the relevant competent authority.</em></p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep all medicines out of the reach and sight of children.</p><p>Do not take Fasigyn after the expiry date stamped on the pack after EXP. The expiry date refers to the last day of that month.</p><p>Store below 25&deg;C. Store in the original package to protect from light.</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is tinidazole. Each tablet contains 500mg of tinidazole.</p><p>The other ingredients are: alginic acid, hydroxypropyl methylcellulose, magnesium stearate, maize starch, microcrystalline cellulose, propylene glycol, sodium lauryl sulphate and titanium dioxide.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Fasigyn 500mg film-coated tablets are round and white with FAS 500 printed on one side. The tablets come in blister packs of 16.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorisation Holder</strong></p><p>Pfizer S.A., Boulevard de la Plain 17, 1050 Brussels, Belgium.</p><p><strong>&nbsp;</strong></p><p><strong>Manufacturer</strong></p><p>Fareva Amboise, Zone Industrielle, 29 route des Industries,</p><p>37530 Poc&eacute;-sur-Cisse, France</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                September 2019 
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">تحتوي أقراص فاسيجين 500 ملجم المغلفة بطبقة رقيقة على 500 ملجم من المادة الفعالة تينيدازول.</p><p dir="RTL">يُعد هذا الدواء عاملًا مضادًا للعدوى. ويُستخدم في علاج مجموعة من حالات العدوى البكتيرية بما في ذلك:</p><p dir="RTL">&bull; حالات عدوى الجلد، أو الدم، أو الصدر، أو الرئة، أو الأعضاء التناسلية، أو بطانة الرحم.</p><p dir="RTL">&bull; عدوى مرتبطة بقرح المعدة، ويتم في هذه الحالة استخدامه بالتزامن مع عقاقير أخرى.</p><p dir="RTL">&bull; حالات العدوى التي تتسبب فيها كائنات حية يُطلق عليها الأوالي، مثل داء الأميبات وداء الجيارديات (حالات عدوى تصيب المعدة) وداء المشعرات (عدوى تصيب الأعضاء التناسلية).</p><p dir="RTL">&bull; حالات العدوى المهبلية (التهاب المهبل) وحالات عدوى اللثة (التهاب اللثة).</p><p dir="RTL">&nbsp;</p><p dir="RTL">ويُستخدم أيضًا قبل إجراء بعض العمليات الجراحية للوقاية من نمو العدوى البكتيرية.</p><p dir="RTL">ينبغي أن تسأل طبيبك، إذا كنت غير متأكد من سبب وصف هذا الدواء لك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>موانع استعمال أقراص فاسيجين 500 ملجم المغلفة بطبقة رقيقة:</strong></p><p dir="RTL">&bull; إذا كنت تعاني من الحساسية (فرط التحسس) تجاه تينيدازول أو أي عقاقير مشابهة له أو تجاه أي من المكونات الأخرى المذكورة في القسم 6. يمكن أن يسبب تفاعل الحساسية الحكة، أو الطفح الجلدي، أو الأزيز.</p><p dir="RTL">&bull; إذا كنت تعاني من أحد اضطرابات الدم أو لديك تاريخ من الإصابة باضطرابات الدم</p><p dir="RTL">&bull; إذا كنت تعاني من مرض متعلق بالجهاز العصبي المركزي (CNS)، بما في ذلك الصرع</p><p dir="RTL">&bull; إذا كنتِ في فترة أول 13 أسبوعًا من حملكِ أو تحاولين الحمل أو ترضعين رضاعة طبيعية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاحتياطات عند استعمال أقراص فاسيجين 500 ملجم المغلفة بطبقة رقيقة</strong></p><p dir="RTL">تحدث إلى طبيبك أو الصيدلي أو الممرضة في حالة ظهور علامات عصبية غير طبيعية (مثل، الدوار، الدوخة، صعوبة التحكم في الحركات) أثناء العلاج باستخدام أقراص فاسيجين 500 ملجم المغلفة بطبقة رقيقة حيث قد يُطلب منك إيقاف علاجك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التداخلات الدوائية من أخذ أقراص فاسيجين 500 ملجم المغلفة بطبقة رقيقة مع أي أدوية أخرى أو أعشاب أو مكملات غذائية</strong></p><p dir="RTL">أخبر طبيبك إذا كنت تتناول أو تناولت مؤخرًا أي أدوية أخرى بما في ذلك تلك التي تباع بدون وصفة طبية.</p><p dir="RTL">ينبغي أن تخبر طبيبك إذا كنت تتناول حاليًا أدوية مسيلة للدم مثل وارفارين للوقاية من الجلطات الدموية لأنه، في هذه الحالة، قد يرغب طبيبك في مراقبتك عن كثب بشكل أكبر.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تناول أقراص فاسيجين 500 ملجم المغلفة بطبقة رقيقة مع الطعام والشراب</strong></p><p dir="RTL">ينبغي ألا تتناول النبيذ أو الجعة أو المشروبات الكحولية أثناء فترة العلاج ولمدة 3 أيام بعد إيقاف العلاج بهذا الدواء، حيث أن تناول تلك المشروبات بالتزامن مع فاسيجين يمكن أن يؤدي إلى الاحمرار والتقلصات المعدية والقيء (الغثيان) والخفقان (الشعور بضربات قلب قوية بشكل زائد).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">ينبغي عدم تناول هذا الدواء، إذا كنتِ في فترة أول 13 أسبوعًا من حملكِ أو كنتِ تحاولين الحمل. استشيري طبيبكِ أو الصيدلي بشأن تناول هذا الدواء في الثلث الثاني والثلث الثالث من الحمل. عليكِ دائمًا استشارة طبيبكِ أو الصيدلي قبل تناول أقراص فاسيجين 500 ملجم المغلفة بطبقة رقيقة أو أي دواء آخر.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الرضاعة الطبيعية</strong></p><p dir="RTL">ينبغي عدم تناول هذا الدواء إذا كنت ترضعين رضاعة طبيعية لأنه يمكن أن تمر كميات قليلة منه إلى لبن الثدي. إذا توقفتِ عن الرضاعة الطبيعية أثناء العلاج، ينبغي ألا تستأنفيها قبل مرور 3 أيام على الأقل من إيقاف تناول أقراص فاسيجين 500 ملجم المغلفة بطبقة رقيقة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الخصوبة</strong></p><p dir="RTL">قد تتأثر الخصوبة لدى الذكور والإناث عند تناول أقراص فاسيجين 500 ملجم المغلفة بطبقة رقيقة، لذا تحدث إلى طبيبك إذا كنت تخطط لإنجاب طفل.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تأثير أقراص فاسيجين 500 ملجم المغلفة بطبقة رقيقة على القيادة واستخدام الآلات</strong></p><p dir="RTL">لا تمارس القيادة أو تستخدم الآلات إذا كان هذا الدواء يجعلك تشعر بالنعاس أو يسبب لك مشاكل متعلقة بالتناسق أو الإحساس (مثل، الشعور بالتنميل أو الضعف).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">عليك دائمًا تناول هذا الدواء بالضبط كما يخبرك طبيبك. استشر طبيبك أو الصيدلي إذا لم تكن متأكدًا مما يجب عليك فعله.</p><p dir="RTL">تناول أقراص فاسيجين 500 ملجم المغلفة بطبقة رقيقة مع كوب من الماء أثناء تناولك وجبة أو بعد انتهائك منها. ابتلع الأقراص كاملة. من الأفضل أن تتناول الدواء في التوقيت نفسه من كل يوم.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاستخدام مع الأطفال الذين تقل أعمارهم عن 12 عامًا</strong></p><p dir="RTL">في حالة العدوى البكتيرية، يوصى بعدم استخدام هذا الدواء مع الأطفال الذين تقل أعمارهم عن 12 عامًا، حيث أنه لم يتم اختباره في هذه الفئة العمرية.</p><p dir="RTL">في حالات العدوى بالأوالي، يمكن استخدام أقراص فاسيجين 500 ملجم المغلفة بطبقة رقيقة مع الأطفال حيث أنه لم يتبين أنه يسبب أي آثار جانبية مختلفة أو مشكلات أكثر مما يفعل في حالة البالغين.</p><p dir="RTL">تعتمد جرعة العلاج ومدة تناوله على العدوى التي يتم علاجها. إذا كنت تخضع للديال (غسيل كلوي)، فقد يقوم طبيبك بوصف جرعة مختلفة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">الجرعات التي تُستخدم بشكل أكثر شيوعًا في حالات العدوى المختلفة تظهر في الجدول أدناه:</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>لعلاج العدوى المرتبطة بقرح المعدة</strong></p><p dir="RTL">الجرعة المعتادة هي قرص واحد (500 ملجم) يتم تناوله مرتين يوميًا. سيصف لك طبيبك على الأرجح دواءين آخرين لتتناولهما مع أقراص فاسيجين 500 ملجم المغلفة بطبقة رقيقة. وسيستمر العلاج عادةً بالأدوية الثلاثة معًا لمدة أسبوع واحد.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>لعلاج أغلب حالات العدوى البكتيرية</strong></p><p dir="RTL">الجرعة المعتادة هي 4 أقراص (2 جم) في اليوم الأول ثم قرصين (1 جم) مرة في اليوم أو قرص واحد (500 ملجم) مرتين في اليوم.</p><p dir="RTL">عادةً ما تتراوح مدة العلاج ما بين 5 إلى 6 أيام.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>لعلاج التهاب المهبل البكتيري (عدوى مهبلية) والتهاب اللثة التقرحي الحاد</strong></p><p dir="RTL"><strong>(عدوى تصيب اللثة)</strong></p><p dir="RTL">الجرعة المعتادة هي 4 أقراص (2 جم) تُعطى في صورة جرعة فردية.</p><p dir="RTL">في حالة التهاب المهبل، يمكن أن يتم إعطاؤكِ 4 أقراص (2 جم) على يومين متتاليين.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للوقاية من حالات العدوى البكتيرية بعد الخضوع لجراحة</strong></p><p dir="RTL">عادةً ما تُعطى 4 أقراص (2 جم) في صورة جرعة ُفردية قبل إجراء الجراحة بحوالي 12 ساعة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>لعلاج حالات العدوى التي تسببها الأوالي</strong></p><p dir="RTL">لعلاج داء الأميبات المعوي (عدوى تصيب المعدة)</p><p dir="RTL"><em><u>البالغون</u></em> الجرعة المعتادة هي 4 أقراص (2 جم) مرة في اليوم لمدة يومين إلى 3 أيام.</p><p dir="RTL"><em><u>الأطفال</u></em> الجرعة المعتادة هي 50 إلى 60 ملجم/كلجم من وزن الجسم مرة في اليوم لمدة 3 أيام.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>لعلاج إصابة الكبد بالأميبا (عدوى تصيب الكبد)</strong></p><p dir="RTL"><em><u>البالغون</u></em> الجرعة المعتادة هي 3 إلى 4 أقراص (1.5 إلى 2 جم) مرة في اليوم لمدة 3 إلى 6 أيام.</p><p dir="RTL"><em><u>الأطفال</u> </em>الجرعة المعتادة هي 50 إلى 60 ملجم/كلجم من وزن الجسم مرة في اليوم لمدة 5 أيام.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>لعلاج داء الجيارديات (عدوى تصيب البطن) وداء المشعرات (عدوى تصيب الأعضاء التناسلية في الذكور والإناث)</strong></p><p dir="RTL"><em><u>البالغون</u></em><em><u> </u></em>الجرعة المعتادة هي 4 أقراص (2 جم) تُعطى في صورة جرعة فردية.</p><p dir="RTL"><em><u>الأطفال</u></em> الجرعة المعتادة هي 50 إلى 75 ملجم/كلجم من وزن الجسم تُعطى في صورة جرعة فردية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">سيحسب طبيبك الجرعة اللازمة للطفل وقد يكرر الجرعة مرة واحدة أخرى إذا لم تتلاشى العدوى تمامًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الجرعة الزائدة من أقراص فاسيجين 500 ملجم المغلفة بطبقة رقيقة</strong></p><p dir="RTL">إذا تناولت جرعة زائدة من هذا الدواء، فأخبر طبيبك أو اتصل بقسم الطوارئ في أقرب مستشفى لك على الفور. أحضر معك ما تبقى من الأقراص.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>نسيان تناول جرعة أقراص فاسيجين 500 ملجم المغلفة بطبقة رقيقة</strong></p><p dir="RTL">إذا نسيت تناول جرعة من هذا الدواء، فتناولها في أسرع وقت ممكن. ثم تناول الجرعة التالية في وقتها المحدد. لا تتناول جرعة مضاعفة لتعويض جرعة منسية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التوقف عن تناول أقراص فاسيجين 500 ملجم المغلفة بطبقة رقيقة</strong></p><p dir="RTL">إذا توقفت عن تناول هذا الدواء في وقت مبكر، فقد تصاب بالعدوى مجددًا. تناول هذا الدواء حتى انتهاء مدة العلاج الكاملة، حتى إذا بدأت تشعر بتحسن.</p><p>إذا كان لديك المزيد من الأسئلة حول استخدام هذا الدواء، فاطلب المشورة من طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثلما هو الحال مع جميع الأدوية، يسبب هذا الدواء آثارًا جانبية، ولكنها لا تصيب الجميع.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أخبر طبيبك في الحال</strong> إذا أصبت بأي من الأعراض التالية بعد تناول هذا الدواء.</p><p dir="RTL">على الرغم من أن تلك الأعراض نادرة جدًا، فإنها يمكن أن تكون شديدة.</p><p dir="RTL">&bull; &nbsp;&nbsp;الحالات المفاجئة من الأزيز، أو صعوبة التنفس، أو تورم الجفون، أو الوجه، أو الشفتين، أو اللسان</p><p dir="RTL">&bull; &nbsp;&nbsp;النوبات</p><p dir="RTL">&nbsp;</p><p dir="RTL">مدرج أدناه الآثار الجانبية الشائعة (التي قد تصيب ما يصل إلى شخص واحد من بين كل 10 أشخاص). قد تختفي هذه الآثار أثناء العلاج، حيث يتكيف جسمك مع الدواء. أخبر طبيبك إذا ما استمرت معاناتك من أي من هذه الآثار الجانبية.</p><p dir="RTL">&bull; &nbsp;&nbsp;الغثيان أو القيء، أو فقدان الشهية، أو الإسهال، أو الشعور بألم أو تقلصات في المعدة</p><p dir="RTL">&bull; &nbsp;&nbsp;الصداع</p><p dir="RTL">&bull; &nbsp;&nbsp;الدوخة (انظر القسم 2 &quot;الاحتياطات عند استعمال أقراص فاسيجين 500 ملجم المغلفة بطبقة رقيقة&quot;)</p><p dir="RTL">&bull; &nbsp;&nbsp;الطفح الجلدي أو الحكة (خاصةً التي تؤثر على الجسم بأكمله).</p><p dir="RTL">&nbsp;</p><p dir="RTL">معدل تكرار الآثار الجانبية التالية غير معروف (لا يمكن تقديره من البيانات المتاحة). ينبغي أن تتصل بطبيبك إذا لاحظت أيًا من التالي:</p><p dir="RTL">&bull; &nbsp;&nbsp;الخدر أو الوخز أو الشعور بالألم أو الضعف في اليدين أو القدمين</p><p dir="RTL">&bull; &nbsp;&nbsp;التخبط أو عدم الثبات</p><p dir="RTL">&bull; &nbsp;&nbsp;الحمى أو القشعريرة وظهور قرح مؤلمة بالفم</p><p dir="RTL">&bull; &nbsp;&nbsp;تقرح أو تورم الفم/اللسان</p><p dir="RTL">&bull; &nbsp;&nbsp;احمرار الوجه أو العنق</p><p dir="RTL">&bull; &nbsp;&nbsp;الدوار</p><p dir="RTL">&bull; &nbsp;&nbsp;التعب</p><p dir="RTL">&bull; &nbsp;&nbsp;البول داكن اللون</p><p dir="RTL">&bull;&nbsp; &nbsp;تغير لون اللسان أو المذاق المعدني الكريه.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد تتسبب أقراص فاسيجين 500 ملجم المغلفة بطبقة رقيقة أحيانًا في حدوث انخفاض مؤقت في تعداد خلايا الدم البيضاء والذي لا يصحبه عادةً أي أعراض.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الإبلاغ عن الأعراض الجانبية</strong></p><p dir="RTL">إذا ظهرت عليك أي آثار جانبية، فتحدث إلى طبيبك أو الصيدلي. يتضمن ذلك أي آثار جانبية محتملة لم يرد ذكرها في هذه النشرة. بإبلاغك عن الآثار الجانبية، يمكنك المساعدة في توفير المزيد من المعلومات حول سلامة هذا الدواء.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>للإبلاغ عن الأعراض الجانبية</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; المملكة العربية السعودية</p><p dir="RTL">&nbsp;</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong>المركز الوطني للتيقظ الدوائي</strong> (NPC)</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp; اتصل بالمركز الوطني للتيقظ والسلامة الدوائية على الرقم 00966112038222 ، تحويلة: 2317-2356-2340</p><p dir="RTL">&middot;&nbsp;&nbsp; مركز الاتصال: 19999</p><p dir="RTL">&middot;&nbsp;&nbsp; فاكس: 00966112057662</p><p dir="RTL">&middot;&nbsp;&nbsp; البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">&middot;&nbsp;&nbsp; الموقع الإلكتروني: https://ade.sfda.gov.sa/</p><p dir="RTL">&nbsp;</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>دول الخليج الأخرى</strong></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em><em>الرجاء الاتصال بالمؤسسات والهيئات الوطنية في كل دولة</em>.</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احتفظ بجميع الأدوية بعيدًا عن متناول ومرأى الأطفال.</p><p dir="RTL">لا تستخدم فاسيجين بعد تاريخ انتهاء الصلاحية المطبوع على العبوة الخارجية بعد رمز انتهاء الصلاحية &quot;EXP&quot;. يشير تاريخ انتهاء الصلاحية إلى آخر يوم في ذلك الشهر.</p><p dir="RTL">يخزن تحت 25 درجة مئوية. يُخزن في عبوته الأصلية لحمايته من الضوء.</p><p dir="RTL">ينبغي عدم التخلص من الأدوية عبر مياه الصرف أو في القمامة المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد هناك حاجة إليها. ستساعد هذه الإجراءات على حماية البيئة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي تينيدازول. يحتوي كل قرص على 500 ملجم من تينيدازول.</p><p dir="RTL">المكونات الأخرى هي: حمض الألجنيك وهيدروكسي بروبيل ميثيل السيليلوز وستيارات المغنسيوم ونشا الذرة وسيليلوز بلوري مكروي وبروبيلين جليكول وسلفات لوريل الصوديوم وثاني أكسيد التيتانيوم.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>أقراص فاسيجين 500 ملجم المغلفة بطبقة رقيقة دائرية الشكل بيضاء اللون وتحمل الرمز &quot;FAS 500&quot; مطبوعًا على أحد الجانبين. تأتي الأقراص في عبوات بها شرائط دواء تحتوي على 16 قرصًا.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>مالك تصريح التسويق</strong></p><p>فايزر إس. أي، بوليفارد دي لا بلاين 17، 1050 بروكسل، بلجيكا.</p><p>&nbsp;</p><p><strong>الجهة المصنعة</strong></p><p>&nbsp;</p><p>Fareva Amboise, Zone Industrielle, 29 route des Industries, 37530 Poc&eacute;-sur-Cisse, France.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            سبتمبر/أيلول 2019
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                FASIGYN 500mg film-coated tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Tinidazole 500mg
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablets.

White, round, biconvex film-coated tablet embossed on one side with “FAS 500”.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment of the following infections:</p><p>&nbsp;</p><p>1. Eradication of <em>Helicobacter pylori</em> associated with duodenal ulcers, in the presence of antibiotic and acid suppressant therapy (see section 4.2).</p><p>&nbsp;</p><p>2. Anaerobic infections such as:</p><p>&nbsp;</p><p>Intraperitoneal infections: peritonitis, abscess.</p><p>Gynaecological infections: endometritis, endomyometritis, tube-ovarian abscess.</p><p>Bacterial septicaemia.</p><p>Post-operative wound infections.</p><p>Skin and soft tissue infections.</p><p>Upper and lower respiratory tract infections: pneumonia, empyema, lung abscess.</p><p>&nbsp;</p><p>3. Non-specific vaginitis.</p><p>&nbsp;</p><p>4. Acute ulcerative gingivitis.</p><p>&nbsp;</p><p>5. Urogenital trichomoniasis in both male and female patients.</p><p>&nbsp;</p><p>6. Giardiasis.</p><p>&nbsp;</p><p>7. Intestinal amoebiasis.</p><p>&nbsp;</p><p>8. Amoebic involvement of the liver.</p><p>&nbsp;</p><p>9. Prophylaxis: The prevention of post-operative infections caused by anaerobic bacteria, especially those associated with colonic, gastro-intestinal and gynaecological surgery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Route: Oral administration during or after a meal.</p><p>&nbsp;</p><p><u>Posology</u></p><p>&nbsp;</p><p>Eradication of H. pylori associated with duodenal ulcers:</p><p>Adults: the usual dose of Fasigyn is 500mg twice daily coadministered with omeprazole 20mg twice daily and clarithromycin 250mg twice daily for 7 days.</p><p>Clinical studies using this 7 day regimen have shown similar <em>H. pylori</em> eradication rates when omeprazole 20mg once daily was used. For further information on the dosage for omeprazole see Astra data sheet.</p><p>&nbsp;</p><p>Anaerobic infections<em>:</em></p><p>Adults: an initial dose of 2g the first day followed by 1g daily given as a single dose or as 500mg twice daily.&nbsp; Treatment for 5 to 6 days will generally be adequate but clinical judgement must be used in determining the duration of therapy, particularly when eradication of infection from certain sites may be difficult.&nbsp; Routine clinical and laboratory observation is recommended if it is considered necessary to continue therapy for more than 7 days.</p><p>&nbsp;</p><p>Children: &lt; 12 years &ndash; there is no data available.</p><p>&nbsp;</p><p>Non-specific vaginitis:</p><p>Adults: non-specific vaginitis has been successfully treated with a single oral dose of 2g. Higher cure rates have been achieved with 2g single doses on 2 consecutive days (total dose 4g).</p><p>&nbsp;</p><p>Acute Ulcerative Gingivitis:</p><p>Adults: a single oral dose of 2g.</p><p>&nbsp;</p><p>Urogenital trichomoniasis:</p><p>(when infection with <em>Trichomonas vaginalis</em> is confirmed, simultaneous treatment of the consort is recommended).</p><p>Adults: a single dose of 2g.</p><p>Children: a single dose of 50 to 75mg/kg of body weight.&nbsp; It may be necessary to repeat this dose.</p><p>&nbsp;</p><p>Giardiasis:</p><p>Adults: a single dose of 2g.</p><p>Children: a single dose of 50 to 75mg/kg of body weight.&nbsp; It may be necessary to repeat this dose.</p><p>&nbsp;</p><p>Intestinal Amoebiasis:</p><p>Adults: a single daily dose of 2g for 2 to 3 days.</p><p>Children: a single daily dose of 50 to 60mg/kg of body weight on each of 3 successive days.</p><p>&nbsp;</p><p>Amoebic involvement in the liver:</p><p>Adults: total dosage varies from 4.5 to 12g, depending on the virulence of the <em>Entamoeba histolytica</em>.</p><p>For amoebic involvement of the liver, the aspiration of pus may be required in addition to therapy with Fasigyn.</p><p>Initiate treatment with 1.5 to 2g as a single oral daily dose for three days. &nbsp;Occasionally when a three day course is ineffective, treatment may be continued for up to six days.</p><p>Children: a single dose of 50 to 60 mg/kg of body weight per day for five successive days.</p><p>&nbsp;</p><p>Use in Renal impairment</p><p>Dosage adjustments in patients with impaired renal function are generally not necessary.&nbsp; However, because tinidazole is easily removed by haemodialysis, patients may require additional doses of tinidazole to compensate.</p><p>&nbsp;</p><p>Prevention of post-operative infection:</p><p>Adults: a single dose of 2g approximately 12 hours before surgery.</p><p>Children: &lt; 12 years &ndash; there is no data available.</p><p><u>&nbsp;</u></p><p>It is recommended that tinidazole be taken during or after a meal.</p><p>&nbsp;</p><p>Use in the elderly<strong>: </strong>there are no special recommendations for this age group.</p><p>&nbsp;</p><p><u>Method of administration</u></p><p>Oral administration.&nbsp; Swallow tablets whole with a glass of water during or after a meal.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.

As with other drugs of similar structure, tinidazole is contraindicated in patients having, or with a history of, blood dyscrasia, although no persistent haematological abnormalities have been noted in clinical or animal studies.

Tinidazole should be avoided in patients with organic neurological disorders.

Tinidazole, other 5-nitroimidazole derivatives or any of the components of this product should not be administered to patients with known hypersensitivity to the drug.

Use of tinidazole is contraindicated during the first trimester of pregnancy and in nursing mothers (see section 4.6).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>As with related compounds, alcoholic beverages should be avoided during Fasigyn therapy because of the possibility of a disulfiram-like reaction (flushing, abdominal cramps, vomiting, tachycardia).&nbsp; Alcohol should be avoided until 72 hours after discontinuing Fasigyn.</p><p>&nbsp;</p><p>Drugs of similar chemical structure have also produced various neurological disturbances such as dizziness, vertigo, incoordination and ataxia.&nbsp; If during therapy with Fasigyn abnormal neurological signs develop, therapy should be discontinued.</p><p>&nbsp;</p><p>Carcinogenicity has been seen in mice and rats treated chronically with metronidazole, another nitroimidazole agent.&nbsp; Although carcinogenicity data is not available for tinidazole, the two drugs are structurally related and therefore there is a potential for similar biologic effects.&nbsp; Mutagenicity results with tinidazole were mixed (positive and negative) (see section 5.3). The use of tinidazole for longer treatment than usually required should be carefully considered.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Alcohol: Concurrent use of tinidazole and alcohol may produce a disulfiram-like reaction and should be avoided, (see section 4.4).</p><p>&nbsp;</p><p>Anticoagulants: Drugs of similar chemical structure have been shown to potentiate the effects of oral anticoagulants.&nbsp; Prothrombin time should be closely monitored and adjustments to the dose of the anticoagulants should be made as necessary.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>&nbsp;</p><p>Animal studies have shown reproductive toxicity (see section 5.3). Tinidazole crosses the placental barrier. Since the effects of compounds of this class on foetal development are unknown, tinidazole is contraindicated in the first trimester of pregnancy.&nbsp;</p><p>&nbsp;</p><p>There is no evidence that tinidazole is harmful during the latter stages of pregnancy, but it should be used in the second and third trimesters only in cases where it is absolutely necessary, when the benefits of therapy outweigh possible risks to both mother and foetus (see section 5.3).</p><p><u>&nbsp;</u></p><p><u>Breast-feeding</u></p><p>Tinidazole is excreted in breast milk.&nbsp; Tinidazole may continue to appear in breast milk for more than 72 hours after administration.&nbsp; Women should not nurse until at least 3 days after having discontinued taking Fasigyn.</p><p>&nbsp;</p><p><u>Fertility</u></p><p>There are no human data on the effect of tinidazole on fertility. Male and female fertility may be impacted based on animal studies that have shown adverse effects on male and female fertility (see section 5.3).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special precautions should be necessary.&nbsp; However, drugs of similar chemical structure, including Fasigyn, have been associated with various neurological disturbances such as dizziness, vertigo, ataxia, peripheral neuropathy (paraesthesia, sensory disturbances, hypoaesthesia) and rarely convulsions.&nbsp; If any abnormal neurological signs develop during Fasigyn therapy, the drug should be discontinued.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Reported side effects have generally been infrequent, mild and self-limiting.</p><p>&nbsp;</p><p>The reported undesirable effects are listed below according to MedDRA system organ class classification and frequency. Within each frequency category, the ADRs are presented in the order of clinical importance. Frequency categories are expressed as: very common (&sup3;1/10); common (&sup3;1/100 to &lt;1/10); uncommon (&sup3;1/1,000 to &lt;1/100); rare (&sup3;1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000); not known (the frequency cannot be estimated from the available data).</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><thead><tr><td style="vertical-align:top"><p><em>System Organ Class</em></p></td><td style="vertical-align:top"><p><em>Common</em></p></td><td style="vertical-align:top"><p><em>Not known</em></p></td></tr></thead><tbody><tr><td style="vertical-align:top"><p>Blood and the lymphatic system disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Leukopenia</p></td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Drug hypersensitivity</p></td></tr><tr><td style="vertical-align:top"><p>Metabolism and nutrition disorders</p></td><td style="vertical-align:top"><p>Decreased appetite</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>Headache</p></td><td style="vertical-align:top"><p>Convulsions</p><p>Neuropathy peripheral</p><p>Paraesthesia</p><p>Hypoaesthesia</p><p>Sensory disturbances</p><p>Ataxia</p><p>Dizziness</p><p>Dysgeusia</p></td></tr><tr><td style="vertical-align:top"><p>Ear and labyrinth disorders</p></td><td style="vertical-align:top"><p>Vertigo</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Vascular disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Flushing</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Vomiting</p><p>Diarrhoea</p><p>Nausea</p><p>Abdominal pain</p></td><td style="vertical-align:top"><p>Glossitis</p><p>Stomatitus</p><p>Tongue discolouration</p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p>Dermatitis allergic</p><p>Pruritis</p></td><td style="vertical-align:top"><p>Angioedema</p><p>Urticaria</p></td></tr><tr><td style="vertical-align:top"><p>Renal and urinary disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Chromaturia</p></td></tr><tr><td style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Pyrexia</p><p>Fatigue</p></td></tr></tbody></table><p>&nbsp;</p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after marketing authorization of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions according to their local country requirements.</p><p>&nbsp;</p><p><strong>To Report side effects</strong></p><p>&nbsp;</p><ul><li>Saudi Arabia</li></ul><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>National Pharmacovigilance Centre ( NPC )</p><p>&middot;&nbsp;&nbsp; Call NPC at +966-11-2038222, Ext 2317-2356-2340</p><p>&middot;&nbsp;&nbsp; Call center : 19999</p><p>&middot;&nbsp;&nbsp; Fax: +966 11 205 7662</p><p>&middot;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><ul><li>Website :https://ade.sfda.gov.sa/&nbsp;&nbsp;</li></ul><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other GCC States</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp; <em>Please contact the relevant competent authority.</em></p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Signs and symptoms of overdosage: There are no reported overdoses in humans with Fasigyn.</p><p>&nbsp;</p><p>Treatment for overdosage: There is no specific antidote for treatment of overdosage with tinidazole.&nbsp; Treatment is symptomatic and supportive. &nbsp;Gastric lavage may be useful.&nbsp; Tinidazole is easily dialysable.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Antiinfectives for systemic use</p><p>ATC code: J 01XD02</p><p>&nbsp;</p><p>Fasigyn is active against both protozoa and obligate anaerobic bacteria.&nbsp; The activity against protozoa involves <em>Trichomonas vaginalis</em>, <em>Entamoeba histolytica</em> and <em>Giardia lamblia.</em></p><p>&nbsp;</p><p>The mode of action of Fasigyn against anaerobic bacteria and protozoa involves penetration of the drug into the cell of the micro-organism and subsequent damage of DNA strands or inhibition of their synthesis.</p><p>&nbsp;</p><p>Fasigyn is active against <em>Helicobacter pylori</em>, <em>Gardnerella vaginalis</em> and most anaerobic bacteria including <em>Bacteroides fragilis</em>, <em>Bacteroides melaninogenicus</em>, Bacteroides spp., Clostridium spp., Eubacterium spp., Fusobacterium spp., Peptococcus spp., Peptostreptococcus spp. and Veillonella spp.</p><p>&nbsp;</p><p><em>Helicobacter pylori (H.pylori)</em> is associated with acid peptic disease including duodenal ulcer and gastric ulcer in which about 95% and 80% of patients respectively are infected with this agent.&nbsp; <em>H.pylori</em> is also implicated as a major contributing factor in the development of gastritis and ulcer recurrence in such patients.&nbsp; Evidence suggests a causative link between <em>H.pylori</em> and gastric carcinoma.</p><p>&nbsp;</p><p>Clinical evidence has shown that the combination of Fasigyn with omeprazole and clarithromycin eradicates 91-96% of <em>H.pylori</em> isolates.</p><p>&nbsp;</p><p>Various different <em>H.pylori</em> eradication regimens have shown that eradication of <em>H.pylori</em> heals duodenal ulcers and reduces the risk of ulcer recurrence.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Fasigyn is rapidly and completely absorbed following oral administration.&nbsp; In studies with healthy volunteers receiving 2g tinidazole orally, peak serum levels of 40-51 micrograms/ml were achieved within two hours and decreased to between 11-19 micrograms/ml at 24 hours. Healthy volunteers who received 800mg and 1.6g tinidazole IV over 10-15 minutes achieved peak plasma concentrations that ranged from 14 to 21mcg/ml for the 800mg dose and averaged 32mcg/ml for the 1.6g dose. At 24 hours postinfusion, plasma levels of tinidazole decreased to 4-5mcg/ml and 8.6mcg/ml respectively, justifying once daily dosing. Plasma levels decline slowly and tinidazole can be detected in plasma at concentrations of up to 1 microgram/ml at 72 hours after oral administration.&nbsp; The plasma elimination half-life for tinidazole is between 12-14 hours.</p><p>&nbsp;</p><p>Tinidazole is widely distributed in all body tissues and also crosses the blood brain barrier, obtaining clinically effective concentrations in all tissues.&nbsp; The apparent volume of distribution is about 50 litres.&nbsp; About 12% of plasma tinidazole is bound to plasma protein.</p><p>&nbsp;</p><p>Tinidazole is excreted by the liver and kidneys.&nbsp; Studies in healthy patients have shown that over 5 days, 60-65% of an administered dose is excreted by the kidneys with 20-25% of the administered dose excreted as unchanged tinidazole.&nbsp; Up to 5% of the administered dose is excreted in the faeces.</p><p>&nbsp;</p><p>Studies in patients with renal failure (creatinine clearance &lt;22ml/min) indicate that there is no statistically significant change in tinidazole pharmacokinetic parameters in these patients, (see section 4.2).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Repeat-dose toxicity </u></p><p><em><u>&nbsp;</u></em></p><p>In a repeat-dose toxicity study in beagle dogs, oral administration of tinidazole increased atrophy of the thymus in both sexes at 300 and 600 mg/kg/day, and atrophy of the prostate in males at all doses of 100, 300 and 600 mg/kg/day. The initial highest dose of 1000 mg/kg/day was lowered to 600 mg/kg/day due to severe clinical signs. The no-observed-adverse-effect level for females was 100 mg/kg/day (approximately 0.9 times the highest human dose based upon plasma AUC).</p><p><u>Genotoxicity/carcinogenicity </u></p><p><u>&nbsp;</u></p><p>Tinidazole showed some evidence of mutagenic potential. In an in vitro mutagenicity assay, tinidazole was mutagenic in the TA 100, S. typhimurium tester strain both with and without metabolic activation.&nbsp; Tinidazole was negative for mutagenicity in a mammalian cell culture system utilising Chinese hamster lung V79 cells (HGPRT test system) and negative for genotoxicity in the Chinese hamster ovary (CHO) sister chromatid exchange assay.&nbsp; Tinidazole was positive for <em>in vivo</em> genotoxicity in the mouse micronucleus assay.</p><p>&nbsp;</p><p>Tinidazole carcinogenicity studies in rats, mice or hamsters have not been reported. However, metronidazole, a chemically-related nitroimidazole, has been reported to be carcinogenic in mice and rats but not hamsters. In several studies metronidazole showed evidence of pulmonary, hepatic, and lymphatic tumorigenesis in mice and mammary and hepatic tumours in female rats.</p><p><u>&nbsp;</u></p><p><u>Reproductive and developmental toxicity </u></p><p><em><u>&nbsp;</u></em></p><p>Tinidazole did not cause malformations in mice or rats. In rats, oral administration of tinidazole reduced embryo-fetal viability and growth retardation (reduced fetal weight and increased skeletal variations) from 500 mg/kg/day (approximately 2 times the highest human therapeutic dose based upon body surface area). In a rat developmental toxicity study, a higher incidence of fetal mortality was noted following oral administration of 600 mg/kg (approximately 3 times the highest human therapeutic dose based upon body surface area). Embryo-fetal toxicity was not observed in mice at the highest dose level of 2,500 mg/kg (approximately 6 times the highest human therapeutic dose based upon body surface area).</p><p>In a male rat fertility study, oral administration of tinidazole reduced fertility at 600 mg/kg/day. Degeneration of the seminiferous tubules in the testes with corresponding effects on spermatogenic measures were noted at 300 and 600 mg/kg/day. The NOAEL for testicular and spermatogenic effects was 100 mg/kg/day (approximately 0.5 times the highest human therapeutic dose based upon body surface area). In another study, oral administration of tinidazole reduced fertility in male rats at 300 mg/kg/day and in female rats at 150 and 300 mg/kg/day.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Fasigyn tablets contain the following ingredients:</p><p>&nbsp;</p><p><strong><em>Tablet core:</em></strong> microcrystalline cellulose, alginic acid, maize starch, magnesium stearate and sodium lauryl sulphate.</p><p>&nbsp;</p><p><strong><em>Film coating:</em></strong> hydroxypropyl methyl cellulose, propylene glycol, titanium dioxide (E171).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years.
Do not use Fasigyn   after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of that month.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Keep out of the sight and reach of children.</p><p>&nbsp;</p><p>Store below 25&ordm;C in a dry place in the absence of light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Fasigyn tablets will be supplied in aluminium foil backed blister packs of 16 500mg tablets consisting of:</p><p>a) 250 micron PVC blister coated with 40gsm of PVdC</p><p>b) 20 micron aluminium foil backing coated with 20gsm PVdC.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p><p>&nbsp;</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p><p>Fasigyn tablets should be swallowed whole.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                MARKETING AUTHORISATION HOLDER

Pfizer S.A., Boulevard de la Plain 17, 1050 Brussels, Belgium.


MANUFACUTRED BY:

Fareva- Amboise, Zone Industrielle, 29 route des Industries,
37530 Pocé-sur-Cisse, France.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                April 2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>